Chief Operating Officer
Charles joined Synexis in April of 2018 and serves as the Chief Operating Officer. Prior to joining Synexis, Charles was Executive Vice President of Operations for Apollo Endosurgery, where he oversaw the manufacturing transition of Allergan Pharmaceuticals’ obesity products and Apollo’s endoscopic product line to Apollo’s Costa Rica facility. Prior to Apollo, Charles was Senior Vice President of Operations at Idev Technologies. Charles scaled Idev’s manufacturing capabilities from the ground up.
Charles began his career at US Surgical Corporation. During his 19 years there, he continued to increase his responsibilities within operations. At the time of its acquisition by Tyco International Ltd. In 1998, Charles was Senior Vice President of Operations at US Surgical. After his time at US Surgical, Charles was President and CEO of CryoGen Inc. and Chief Operating Officer of Power Medical Interventions.
Charles holds a bachelor’s in economics from Fordham University and an M.B.A. from Long Island University